Summary & Overview
HCPCS Q9974: Morphine Sulfate Preservative-Free Injection, 10 mg
HCPCS Level II code Q9974 designates a preservative-free 10 mg vial of morphine sulfate formulated for epidural or intrathecal use. This specialized formulation is used in neuraxial pain management and perioperative analgesia where preservative-free preparations are required to reduce neurotoxicity risk. Nationally, accurate coding of neuraxial opioid products matters for safe medication use, supply-chain tracking, and consistent billing across acute care and ambulatory procedural settings.
Key payers in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for neuraxial morphine, typical sites of service, and the scope of the code. The publication summarizes benchmark topics relevant to payers and providers — including coverage considerations, utilization patterns, and coding alignment for neuraxial analgesic products — and flags where data were not provided in the input.
This summary is written for a national audience and focuses on the practical meaning of the code, its clinical use for epidural and intrathecal analgesia, and the payer landscape that commonly processes claims for such products. Data not available in the input are noted where applicable.
Billing Code Overview
HCPCS Level II code Q9974 represents injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg. This code describes a single-dose pharmaceutical product formulated specifically for neuraxial administration (epidural or intrathecal) of morphine sulfate without preservatives.
-
Service type: Parenteral opioid analgesic for neuraxial (epidural/intrathecal) administration
-
Typical site of service: Hospital inpatient, hospital outpatient, ambulatory surgery centers, and specialty pain clinics where epidural or intrathecal injections are performed
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 56-year-old patient with chronic radicular lumbar pain refractory to oral analgesics presents to an outpatient pain management clinic for epidural steroid injection planning. After assessment by an interventional pain physician, the decision is made to perform an epidural injection under fluoroscopic guidance. During the procedure the clinician administers preservative-free morphine sulfate for epidural analgesia or as an intrathecal test dose following established institutional protocols. Typical workflow: pre-procedure history and consent; verification of indication and allergies; IV access and monitoring; sterile preparation and fluoroscopic localization; administration of local anesthetic and contrast for confirmation; injection of preservative-free morphine sulfate Q9974 in the epidural space (or intrathecal space when indicated) with post-procedure monitoring for respiratory depression and urinary retention; discharge with documented instructions and analgesic precautions. Typical sites of service include outpatient pain management clinics, ambulatory surgical centers, and hospital outpatient departments where fluoroscopic guidance and monitoring capabilities are available.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the day of a procedure | Use when a distinct E/M visit is performed and documented on the same day as administration. |